Aviceda Publications

At Aviceda, we have developed an active and collaborative research department, with a core mission to advance the fundamental scientific understanding that underpins our clinical assets.

2024

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity

Husam Nawafleh, Nagwa Zeinelabdin, Michelle K. Greene, PhD, Anitha Krishnan, PhD, Linus Ho, MD, PhD, Mohamed Genead, MD, Derek Kunimoto, MD, Christopher J. Scott, PhD, Michael J. Tolentino, MD, Salem Chouaib, PhD

Pharmaceuticals (Basel)

PolySialic Acid Nanoparticles Actuate Complement-Factor-H- Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration

Sheri L. Peterson, PhD, Anitha Krishnan, PhD, Diyan Patel, MS, Amit Lad, PhD, Jutamas Shaughnessy, MD, PhD, Sanjay Ram, MD, David Callanan, MD, Derek Kunimoto, MD, Mohamed Genead, MD, Michael J. Tolentino, MD

Pharmaceuticals - MDPI

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials

Anitha Krishnan, PhD, David Callanan, MD, Victor G. Sendra, PhD, Amit Lad, PhD, Sunny Christian, Ravinder Earla, PhD, Ali Khanehzar, PhD, Andrew J. Tolentino, BS, Valory Anne Sarmiento Vailoces, Michelle K. Greene, PhD, Christopher J. Scott, PhD, Derek Kunimoto, MD, Tarek Hassan, MD, Mohamed Genead, MD, Michael J. Tolentino, MD

Pharmaceuticals - MDPI

2023

Sialic Acid Mimetic Microglial Sialic Acid-Binding Immunoglobulin-like Lectin Agonism: Potential to Restore Retinal Homeostasis and Regain Visual Function in Age-Related Macular Degeneration

Michael J. Tolentino, MD, Andrew J. Tolentino, BS, Elizabeth M. Tolentino, Anitha Krishnan, PhD, Mohamed Genead, MD

Pharmaceuticals - MDPI

PolySialic acid-nanoparticles inhibit macrophage mediated inflammation through Siglec agonism: a potential treatment for age related macular degeneration

Anitha Krishnan, PhD, Victor G. Sendra, PhD, Diyan Patel, MS, Amit Lad, PhD, Michelle K. Greene, PhD, Peter Smyth, PhD, Samantha A. Gallaher, Úna M. Herron, PhD, Christopher J. Scott, PhD, Mohamed Genead, MD, Michael J. Tolentino, MD

Frontiers in Immunology

SIGLECs the Main Self-Pattern Recognition Receptors of the Immune System. A Promising Target for Inflammatory Modulation

Andrew J. Tolentino, BS, Michael J. Tolentino, MD, Elizabeth M. Tolentino, Anitha Krishnan, PhD, Mohamed Genead, MD

American Journal of Biomedical Science & Research

Glycoimmune Therapy as a Novel Treatment Approach for Geographic Atrophy

Sophie J. Bakri, MD, MBA, Jeffrey S. Heier, MD, Arshad M. Khanani, MD, Ma, FASRS, Baruch D. Kuppermann, MD, PhD, Carl D. Regillo, MD, FACS, FASRS, Peter K. Kaiser, MD, FASRS

2021

Targeting Innate Immune Activity in Age-Related Macular Degeneration Promising candidate molecules are in later stages of development.

Carl D. Regillo, MD, FACS, FASRS; Jeffrey S. Heier, MD

Retinal Physician, Volume: 18, Issue: April 2021, page(s): 42-45